DWS Health Care Typ O NC
Open Ended Investment Company domiciled in Germany
Key Information
Legal Documents
Performance
Analysis

Fund Profile

Category: Open Ended Investment Company

The fund is actively managed. The fund is managed in reference to a benchmark. The objective of the investment policy is to achieve sustained capital appreciation that exceeds the benchmark (MSCI World Health Care TR Net). In order to achieve this, the fund invests mainly in equities of international companies whose revenues or earnings, as reported in the most recent annual report, were generated predominantly from activities in the health care sector, or whose expenditures take place predominantly in this sector. The health care sector includes all activities and services related to the research, development, manufacturing and distribution of pharmaceuticals and medical technology, as well as services in the field of treatment and prevention of diseases. In this context, the selection of individual investments is the responsibility of the fund management. The majority of the fund's securities or their issuers are expected to be components of the benchmark. The fund management will use its discretion to invest in securities and sectors that are not included in the benchmark in order to take advantages of specific investment opportunities. The strategy provides investors with access to the market for global issuers. The fund’s positioning may deviate substantially from the benchmark (e.g., due to a positioning outside of the benchmark or considerable underweighting or overweighting). Due to the fund strategy characteristics already mentioned, the portfolio’s deviation from the benchmark is generally relatively high. Despite the fact that the fund aims to outperform the benchmark, the potential outperformance might be limited depending on the prevailing market environment (e.g. less volatile market environment) and actual positioning versus the benchmark. The currency of the fund is EUR. Returns and gains are not distributed but are reinvested in the fund. You may request the redemption of shares generally on a daily basis.

Morningstar Rating
More information about the calculation of the Morningstar Ratings
Risk and reward profile
6
Lower Risk
Possible Lower
Returns
Higher Risk
Possible Higher
Returns
Key Information
Closing Price 27/11/2020290.91
Morningstar categorySector Equity Healthcare
CurrencyEUR
Distribution statusAccumulating
ISINDE0009769851
Inception Date10/11/1997
Minimum initial amount100.00 EUR
Fees And Charges
Entry feeNone
Custody feeNone
Exit feeNone
Ongoing charge1.71% of which 0.90% is paid to MeDirect
Fund management company
AddressDWS Investment S.A. 2, Boulevard Konrad Adenauer 1115 Luxembourg Luxembourg 1115 Luxembourg
Manager NameOliver Schweers
Manager Start Date01/08/2003
Websitewww.dws.lu
Total Net Assets (mil)279.61 EUR (31/10/2020)
UCITSYes
AdministratorDWS Investment GmbH

Documents

Prospectus
en 01/07/2020
Annual Report
en 30/09/2019
Semi Annual Report
en 31/03/2020
Morningstar Report
30/11/2020

Performance

Historical returns are no guarantee for future performances. Investing in Financial markets and securities involves risk. Past performance is not a guarantee of future results. Investment losses may occur and investors could lose some or all of their investment in the Fund.
Entry fees, purchase charges, custody fees, exit fees, sale charges and taxes are not included in the calculation of past performance. Ongoing charges (including management fees, administrative fees and other costs) have been taken in to account, as they are already included in the price/NAV of the fund.
Annualised performance in EUR
PeriodAnnualised returnDate
1 year2.12%27/11/2020
3 years10.62%27/11/2020
5 years4.31%27/11/2020
10 years13.22%27/11/2020
Since launch7.89%27/11/2020
Cumulative performance in EUR
Performance
YTD 01/01/20200.00
1 month2.35
3 months1.96
6 months0.60
Quarterly Returns
Q 1Q 2Q 3Q 4
2020-11.72%10.16%0.31%-
20199.92%1.69%1.33%11.56%
2018-5.08%9.49%10.27%-8.41%
20176.44%-0.46%-1.49%-0.67%
2016-14.64%5.74%-1.50%1.72%
Dividend

Asset Allocation
% Long% Short% Net Assets
Stock92.95%0.00%92.95%
Bond0.00%0.00%0.00%
Cash1.30%0.14%1.16%
Other5.89%0.00%5.89%
Return/Risk Analysis
Risk Measurement1 Year3 Years5 Years
Standard Deviation
20.2215.6514.70
Sharpe Ratio
0.390.450.33
Sortino Ratio
0.690.730.48
Positive Months5.0021.0031.00
Negative Months6.0014.0028.00
Worst Month-8.09-8.95-11.92
World Regions
Region%
United States66.01
Eurozone14.24
Europe - ex Euro6.70
United Kingdom4.58
Japan1.18
Asia - Emerging0.24
Stock Sector Weighting
Sector% of Equity
Healthcare92.95
Top 10 Holdings
HoldingSectorCountry% of Assets
UnitedHealth Group Inc HealthcareUnited States7.84
Medtronic PLC HealthcareUnited States7.60
Pfizer Inc HealthcareUnited States6.43
DWS Deutsche GLS- Managed Dollar Fund Z Ireland5.89
Merck & Co Inc HealthcareUnited States5.58
Agilent Technologies Inc HealthcareUnited States4.16
Royal Philips NV HealthcareNetherlands3.98
AstraZeneca PLC HealthcareUnited Kingdom3.89
Novartis AG HealthcareSwitzerland3.86
Johnson & Johnson HealthcareUnited States3.70
Classification of Morningstar Category
Ranking1 Year2 Years3 Years5 Years
Top 25%
Category above the average
Category below the average
Bottom 25%
Morningstar Style Box
Equity Style
Large
Size
Mid
Small
Value
Blend
Growth
Style
290.91
Closing Price
All key information and documents must be reviewed before being able to Invest.